when is retatrutide expected to be available Retatrutide, a new weight loss drug not on the market yet, showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Retatrutide vs Mounjaro vs Ozempic:

Research protocols incorporating this intervention report improved outcomes compared to supportive care alone

Publishers note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Turcu AF, Rege J, Auchus RJ, et al

Coronary Revascularization Procedures Trials including LEADER, AMPLITUDE-O, and REWIND found no effect of GLP-1 RAs on the risk of coronary revascularization ( p = 0.46) included 9,901 individuals with T2DM ( Chronic Coronary Syndromes, Vasospastic and Microvascular Angina Existing evidence on the role of GLP-1 RAs on CCS and vasospastic and microvascular angina is scarce